Back to search
FDAFDA · Food and drugs·Recall number D-1504-2020

DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0

Published August 26, 2020 · Recall initiated: July 21, 2020

Summary

FDA records drug Class I recall D-1504-2020, published August 26, 2020 and initiated July 21, 2020. Recalling firm: Ferring Pharmaceuticals Inc; Status: Terminated; Reported quantity: 15,175 nasal sprays; Lot: Lot #: N14695F, exp. date 08/2020 N15627C, exp. date 10/2020 P11319P, exp. date 01/2021 P11706F, exp. date 04/2021 R11842C, exp. date 03/2022; R13637E, exp. date 06/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent Drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Ferring Pharmaceuticals Inc
Distributor
Nationwide within the United States.
Lot
Lot #: N14695F, exp. date 08/2020 N15627C, exp. date 10/2020 P11319P, exp. date 01/2021 P11706F, exp. date 04/2021 R11842C, exp. date 03/2022; R13637E, exp. date 06/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0 recalled?

Yes. FDA published recall D-1504-2020 on August 26, 2020. Reported hazard: Superpotent Drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter